These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33. Hereditary breast and ovarian cancer (HBOC): clinical features and counseling for BRCA1 and BRCA2, Lynch syndrome, Cowden syndrome, and Li-Fraumeni syndrome. Shulman LP Obstet Gynecol Clin North Am; 2010 Mar; 37(1):109-33, Table of Contents. PubMed ID: 20494261 [TBL] [Abstract][Full Text] [Related]
37. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group Genet Med; 2009 Jan; 11(1):35-41. PubMed ID: 19125126 [TBL] [Abstract][Full Text] [Related]
38. Epigenetic mechanisms in the pathogenesis of Lynch syndrome. Peltomäki P Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998 [TBL] [Abstract][Full Text] [Related]
39. A new strategy to screen MMR genes in Lynch Syndrome: HA-CAE, MLPA and RT-PCR. Perez-Cabornero L; Velasco E; Infante M; Sanz D; Lastra E; Hernández L; Miner C; Duran M Eur J Cancer; 2009 May; 45(8):1485-93. PubMed ID: 19250818 [TBL] [Abstract][Full Text] [Related]
40. Evidence of constitutional MLH1 epimutation associated to transgenerational inheritance of cancer susceptibility. Crépin M; Dieu MC; Lejeune S; Escande F; Boidin D; Porchet N; Morin G; Manouvrier S; Mathieu M; Buisine MP Hum Mutat; 2012 Jan; 33(1):180-8. PubMed ID: 21953887 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]